PS.

NHS Framework for Midland & East Branded Medicines, Tranche B & Annual Tranche

NHS EnglandcontractFind a Tender ↗Ref ocds-h6vhtk-036b1b32014L0024active

Estimated value

—

goods

Awarded value

—

Suppliers

44

10 SME

Lots

2

44 awarded

Published

15 Mar 2023

Description

NHS Framework for Midlands and East Branded Medicines - Tranche B and Annual Tranche.<br/> <br/>Offer reference number: CM/PHR/20/5608<br/> <br/>CM/PHR/20/5608/01 - NHS Framework for Midlands and East Branded Medicines - Tranche B. Period of framework: 1 March 2023 to 28 February 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months<br/><br/>CM/PHR/20/5608/02 - NHS Framework for Midlands and East Branded Medicines - Annual Tranche. Period of framework: 1 March 2023 to 29 February 2024 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months

Scope

Reference
CM/PHR/20/5608
Commercial tool
Standalone contract
Contract dates
01 Mar 2023 to 28 Feb 2025
Main category
goods
CPV classifications
33600000
Contract locations
UK

Award criteria

Criteria the buyer will use to evaluate bids.

NameDescriptionTypeWeighting
——price—

Submission & procedure

Procedure
Open procedure

Award details· 44 awards

Awarded supplier(s), contract period and value as published in the award notice.

Awarded value

—

Award date

—

Contract start

—

Contract end

—

Awarded to
SL
Sandoz Ltd
SME
TU
Teva UK Limited
RP
Roche Products Ltd
KP
Kent Pharma Ltd
SME
UG
UL Global Pharma
CH
Celltrion Healthcare United Kingdom Limited
MS
Merck Sharpe and Dohme (UK) Limited
MY
Mylan
SME
JL
Janssen-Cilag Ltd
BP
Bayer Plc
PL
Pfizer Ltd
NH
Neon Healthcare Ltd
SME
AP
Aventis Pharma ltd t/a Sanofi
IP
Ipsen
BI
Biogen
TU
Takeda UK Ltd
SME
MS
Merck Serono Limited
NN
Novo Nordisk
EL
Eli Lilly and Company Ltd
CP
CST Pharma Limited
SME
GS
Gilead Sciences Limited
TL
Typharm Ltd
SME
TU
Teva UK Limited
RP
Roche Products Ltd
UG
UL Global Pharma
CH
Celltrion Healthcare United Kingdom Limited
MS
Merck Sharpe and Dohme (UK) Limited
AL
Amgen Ltd
TA
Thornton and Ross Ltd
JL
Janssen-Cilag Ltd
AL
Accord-UK Ltd
PL
Pfizer Ltd
GU
GlaxoSmithKline UK Limited
AL
Abbvie Ltd
AS
AstraZeneca
SME
AP
Aventis Pharma ltd t/a Sanofi
TU
Takeda UK Ltd
SME
OP
Organon Pharmaceuticals UK Ltd
ZP
Zentiva Pharma UK Ltd
NN
Novo Nordisk
EL
Eli Lilly and Company Ltd
GR
Gedeon Richter UK Ltd
SME
AL
Almirall
UP
UCB Pharma Ltd (primary)

Lots · 2 total

Divisions of the contract. Each lot can be awarded separately.

View all →
LotTitleEst. valueStatus
1CM/PHR/20/5608/01 - NHS Framework for Midlands & East Branded - Tranche B£491.5mcancelled
2CM/PHR/20/5608/02 - NHS Framework for Midlands and East Branded - Annual£384.3mcancelled